Skip to main content

Butylated hydroxytoluene (BHT)

ADVERTISEMENT
Identification
Molecular formula
C15H24O
CAS number
128-37-0
IUPAC name
6-tert-butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethyl-phenol
State
State

At room temperature, Butylated hydroxytoluene (BHT) is in a solid state, typically presented as a white crystalline solid.

Melting point (Celsius)
70.00
Melting point (Kelvin)
343.15
Boiling point (Celsius)
265.00
Boiling point (Kelvin)
538.15
General information
Molecular weight
220.35g/mol
Molar mass
220.3500g/mol
Density
1.0480g/cm3
Appearence

Butylated hydroxytoluene (BHT) appears as a white crystalline solid or powder. It is known for its excellent stability and lack of solubility in water, which makes it ideal for use as an antioxidant in various industrial and food preservation applications.

Comment on solubility

Solubility of 6-tert-butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethyl-phenol

The solubility of the compound C15H24O, also known as 6-tert-butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethyl-phenol, can be influenced by several factors. Understanding its solubility profile is crucial for various applications in chemical and pharmaceutical sectors. Here are a few key points to consider:

  • Solvent Dependence: This compound is likely to be soluble in organic solvents such as ethanol, methanol, and acetone, but may exhibit limited solubility in polar solvents like water due to its hydrophobic tert-butyl and phenolic groups.
  • Temperature Impact: As with many organic compounds, solubility may increase with temperature. Therefore, measuring solubility at varying temperatures can provide valuable insights.
  • pH Sensitivity: The presence of the phenolic function may lead to changes in solubility when the pH is altered, as phenols can ionize under basic conditions, potentially increasing solubility in aqueous solutions.

In conclusion, the solubility of C15H24O is a complex interplay of its chemical structure, the nature of solvents used, temperature, and pH. Conducting thorough solubility studies is essential for maximizing its utilization in various applications.

Interesting facts

Exploring 6-tert-butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethyl-phenol

This fascinating compound, often pursued in the realm of medicinal chemistry, offers several intriguing aspects that highlight its potential applications and significance. Here are some key points to consider:

  • Structural Complexity: The compound showcases a multifaceted structure, integrating various functional groups—this enhances its potential reactivity and biological activity.
  • Biological Relevance: The presence of the imidazol moiety hints at potential pharmacological properties. Imidazoles are known for their roles in numerous biological processes and as precursors in drug designs.
  • Antioxidant Potential: The presence of phenolic groups may impart antioxidant capabilities, contributing to its potential effectiveness in combating oxidative stress, a key factor in many diseases.
  • Pharmaceutical Chemistry: This compound reflects ongoing research interest in creating novel therapeutic agents, particularly in oncology or neuropharmacology, leveraging its unique structural attributes.

As the scientific community continues its exploration of compounds like 6-tert-butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethyl-phenol, we can anticipate exciting advancements in understanding how such molecules can influence health and disease.

Synonyms
oxymetazoline
1491-59-4
Oxymethazoline
Hazol
Oximetazolinum
Oxylazine
Rhinofrenol
Iliadin
Sinerol
Nafrine
Navisin
Nezeril
Oxymetozoline
Oximetazolina
Oxymetazolinum
Rhinolitan
Afrin
6-tert-Butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethylphenol
Nasacon
Operil
Phenol, 3-[(4,5-dihydro-1H-imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethyl-
6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol
HSDB 3143
2-(4-tert-Butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline
Oxymetazolinum [INN-Latin]
Oximetazolina [INN-Spanish]
6-tert-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol
oxymetazolina
H 990
UNII-8VLN5B44ZY
EINECS 216-079-1
8VLN5B44ZY
BRN 0886303
CHEBI:7862
Oxymetazoline (INN)
Phenol, 3-((4,5-dihydro-1H-imidazol-2-yl)methyl)-6-(1,1-dimethylethyl)-2,4-dimethyl-
DTXSID3040691
Phenol, 6-tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethyl-
3-[(4,5-Dihydro-1H-imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol
DTXCID1020691
Navasin
Phenol, 6-t-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethyl-
Vicks Sinex
NCGC00015766-08
OXYMETAZOLINE [INN]
Oxymetazolinum (INN-Latin)
Oximetazolina (INN-Spanish)
Oxymetazoline [INN:BAN]
CAS-1491-59-4
Operil (TN)
oxymetazoline hydrochloride crystalline
6-tert-butyl-3-((4,5-dihydro-1H-imidazol-2-yl)methyl)-2,4-dimethylphenol
6-tert-Butyl-3-[(4,5-dihydro-1H-imidazol-2-yl)methyl]-2,4-dimethylphenol
3-((4,5-dihydro-1H-imidazol-2-yl)methyl)-6-(1,1-dimethylethyl)-2,4-dimethylphenol
Nasivine (Salt/Mix)
Spectrum_001051
Tocris-1142
Prestwick0_000224
Prestwick1_000224
Prestwick2_000224
Prestwick3_000224
Spectrum2_000998
Spectrum3_000533
Spectrum4_000464
Spectrum5_001114
Lopac-O-2378
OXYMETAZOLINE [MI]
Biomol-NT_000161
CHEMBL762
OXYMETAZOLINE [HSDB]
Lopac0_000903
SCHEMBL24301
BSPBio_000267
BSPBio_002145
GTPL124
KBioGR_000908
KBioSS_001531
OXYMETAZOLINE [VANDF]
cid_66259
DivK1c_000567
SPBio_001095
SPBio_002188
OXYMETAZOLINE [WHO-DD]
BPBio1_000295
BPBio1_000419
BDBM30712
KBio1_000567
KBio2_001531
KBio2_004099
KBio2_006667
KBio3_001645
A14AA05
R01AA05
R01AB07
S01GA04
NINDS_000567
HMS2089G03
ALBB-036521
Tox21_110217
STK075254
3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethyl-6-tert-butyl-phenol
AKOS007930348
Tox21_110217_1
AC-6370
CAS-151615
CCG-204985
DB00935
SDCCGSBI-0050878.P005
IDI1_000567
NCGC00015766-01
NCGC00015766-02
NCGC00015766-03
NCGC00015766-04
NCGC00015766-05
NCGC00015766-06
NCGC00015766-07
NCGC00015766-09
NCGC00015766-10
NCGC00015766-11
NCGC00015766-13
NCGC00015766-16
NCGC00015766-21
NCGC00022345-02
NCGC00022345-04
NCGC00022345-05
NCGC00022345-06
HY-12722
SBI-0050878.P004
CS-0012298
H-990
NS00005342
C07363
D08322
G78135
AB00053513-12
AB00053513-13
AB00053513_14
AB00053513_15
EN300-23521946
L000459
Q417813
BRD-K16195444-001-01-7
BRD-K16195444-003-16-1
BRD-K16195444-003-24-5
BRD-K16195444-003-25-2
BRD-K16195444-003-26-0
6-tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethyl-phenol;hydrochloride
6-tert-Butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethylphenol #
6-tert-butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethyl-phenol;hydrochloride
Phenol, 6-tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethyl- (7CI,8CI)
216-079-1
Phenol, 3-[(4,5-dihydro-1H-imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethyl- (9CI)